US Patent 9493740 Immunotherapy of cancer using genetically engineered GD2-specific T cells
Patent 9493740 was granted and assigned to Baylor College of Medicine on November, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+368 characters)
Article
Patent abstract
The present invention concerns immunotherapy for cancers having cells that comprise the ganglioside GD2 antigen. In specific embodiment, T cells having a chimeric receptor that targets GD2 is employed. In particular cases, the chimeric receptor comprises antibody, cytoplasmic signaling domain from the T cell receptor, and/or costimulatory molecule(s).
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Claudia Rossig0
Gianpietro Dotti0
Malcolm Brenner0
Nabil Ahmed0
Stephen M. G. Gottschalk0
Zakaria Grada0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09493740 Immunotherapy of cancer using genetically engineered GD2-specific T cells US Patent 9493740 Immunotherapy of cancer using genetically engineered GD2-specific T cells
Infobox
Patent Number
094937400
Patent Number
94937400
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
094937400
Date of Patent
November 15, 2016
0Patent Application Number
138209310
Date Filed
September 8, 2011
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09493740 Immunotherapy of cancer using genetically engineered GD2-specific T cells
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09493740
Date of patent
November 15, 2016
Patent application number
13820931
Date Filed
September 8, 2011
Patent primary examiner
Find more entities like US Patent 9493740 Immunotherapy of cancer using genetically engineered GD2-specific T cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
